Contract Pharmaceutical Research Services
The Contract Pharmaceutical Research Services industry provides a breadth of research and development (R&D) services to manufacturers in pharmaceutical industries. Over the past five years, brand-name drug producers have experienced increasing threats from generic brands due to patent expirations. Additionally, increased regulation and emergent health economics and outcomes research have pressured pharmaceutical companies to control costs and increase research efficiency. As a result, drug manufacturers are increasingly outsourcing R&D functions to industry operators, increasing industry revenue. The industry is also poised for continued growth during the five-year period to 2024. During this time, the pharmaceutical industry is expected to continue to devote an increasing share of capital to researching orphan drugs and rare oncology medications. Furthermore, an increase in R&D expenditure and research outsourcing over the past five years was also the result of pharmaceutical companies seeking to replenish thinning pipelines due to patent expirations.
The industry provides a range of research and development services to pharmaceutical manufacturers, including laboratory testing, preclinical and clinical trials, commercialization and post-market surveillance.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook